A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study
- Resource Type
- Article
- Source
- In
eClinicalMedicine December 2022 54 - Subject
- Language
- ISSN
- 2589-5370